Gómez Beatriz L
School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellin, Colombia.
Rev Iberoam Micol. 2014 Jan-Mar;31(1):35-41. doi: 10.1016/j.riam.2013.09.009. Epub 2013 Nov 16.
The diagnosis of endemic and invasive fungal disease remains challenging. Molecular techniques for identification of fungi now play a significant and growing role in clinical mycology and offer distinct advantages as they are faster, more sensitive and more specific. The aim of this mini-review is to provide an overview of the state of the art of molecular diagnosis of endemic and invasive fungal diseases, and to emphasize the challenges and current need for standardization of the different methods. The European Aspergillus PCR Initiative (EAPCRI) has made significant progress in developing a standard for Aspergillus polymerase chain reaction (PCR), but recognizes that the process will not be finished until clinical utility has been established in formal and extensive clinical trials. Similar efforts should be implemented for the diagnosis of the other mycoses in order to fully validate the current methods or reinforce the need to design new ones. This manuscript is part of the series of works presented at the "V International Workshop: Molecular genetic approaches to the study of human pathogenic fungi" (Oaxaca, Mexico, 2012).
地方性和侵袭性真菌病的诊断仍然具有挑战性。目前,用于真菌鉴定的分子技术在临床真菌学中发挥着重要且日益重要的作用,并且具有明显优势,因为它们更快、更灵敏、更特异。本小型综述的目的是概述地方性和侵袭性真菌病分子诊断的现状,并强调不同方法标准化面临的挑战和当前需求。欧洲曲霉聚合酶链反应倡议(EAPCRI)在制定曲霉聚合酶链反应(PCR)标准方面取得了重大进展,但认识到在正式和广泛的临床试验中确立临床实用性之前,该过程不会完成。对于其他真菌病的诊断,应开展类似的工作,以便充分验证现有方法或强化设计新方法的必要性。本手稿是在“第五届国际研讨会:人类致病真菌研究的分子遗传学方法”(2012年,墨西哥瓦哈卡)上发表的系列作品的一部分。